RSM logo
JRSM

Home Current issue Browse archive Alerts About the journal Feedback
 
J R Soc Med 2004;97:511-520
doi:10.1258/jrsm.97.11.511
© 2004 Royal Society of Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Send a Quick Comment
Right arrow Alert me when this article is cited
Right arrow Alert me when Quick Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkin, T. J
Right arrow Articles by Voss, L. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Metabolic syndrome: maladaptation to a modern world

Terence J Wilkin MD FRCP     Linda D Voss PhD  

Department of Endocrinology & Metabolism, Peninsula Medical School (Plymouth campus), Level 7, Derriford Hospital, Plymouth PL6 8DH, UK



View larger version (15K):

[in a new window]
 
Figure 1. The shift in distribution of BMI of UK adults between the 1970s (black) and the 1990s (open).

Both the median and the mean have moved, suggesting that the whole of society is involved. Modified from ref. 3

 


View larger version (13K):

[in a new window]
 
Figure 2. Schematic representation of the feedback loop controlling blood glucose.

If the islets fail (type 1 diabetes), glucose rises because insulin falls. If the tissues fail (type 2 diabetes), insulin rises because glucose rises

 


View larger version (17K):

[in a new window]
 
Figure 3. The metabolic wheel. Insulin resistance at its centre simultaneously drives a number of metabolic processes. The spokes are each linked through the hub, rather than to each other. PAI-1=plasminogen activator inhibitor 1; PCV=haematocrit

 


View larger version (105K):

[in a new window]
 
Figure 4. A transverse abdominal CT scan showing intraabdominal visceral fat in black (area 13459 mm2, metabolically harmful) but, in addition, a substantial amount of subcutaneous fat (area 5823 mm2, metabolically harmless)

 


View larger version (13K):

[in a new window]
 
Figure 5. The relationship between visceral adiposity (% central abdominal fat), BMI and insulin resistance. BMI does not inform on fat distribution and is a poor proxy for insulin resistance (After Ref. 47)

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



MDU Exam Doctor